233 related articles for article (PubMed ID: 22180482)
41. Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry.
Espinet B; Ferrer A; Bellosillo B; Nonell L; Salar A; Fernández-Rodríguez C; Puigdecanet E; Gimeno J; Garcia-Garcia M; Vela MC; Luño E; Collado R; Navarro JT; de la Banda E; Abrisqueta P; Arenillas L; Serrano C; Lloreta J; Miñana B; Cerutti A; Florensa L; Orfao A; Sanz F; Solé F; Dominguez-Sola D; Serrano S
Clin Cancer Res; 2014 Feb; 20(4):1007-19. PubMed ID: 24352646
[TBL] [Abstract][Full Text] [Related]
42. CD200 expression in plasma cells of nonmyeloma immunoproliferative disorders: clinicopathologic features and comparison with plasma cell myeloma.
Olteanu H; Harrington AM; Kroft SH
Am J Clin Pathol; 2012 Dec; 138(6):867-76. PubMed ID: 23161721
[TBL] [Abstract][Full Text] [Related]
43. Determination of CD43 and CD200 surface expression improves accuracy of B-cell lymphoma immunophenotyping.
Hoffmann J; Rother M; Kaiser U; Thrun MC; Wilhelm C; Gruen A; Niebergall U; Meissauer U; Neubauer A; Brendel C
Cytometry B Clin Cytom; 2020 Nov; 98(6):476-482. PubMed ID: 32716606
[TBL] [Abstract][Full Text] [Related]
44. CD200 is a new prognostic factor in multiple myeloma.
Moreaux J; Hose D; Reme T; Jourdan E; Hundemer M; Legouffe E; Moine P; Bourin P; Moos M; Corre J; Möhler T; De Vos J; Rossi JF; Goldschmidt H; Klein B
Blood; 2006 Dec; 108(13):4194-7. PubMed ID: 16946299
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of CD307a expression patterns during normal B-cell maturation and in B-cell malignancies by flow cytometry.
Auat M; Cardoso CC; Santos-Pirath IM; Rudolf-Oliveira RCM; Matiollo C; Lange BG; da Silva JP; Dametto GC; Pirolli MM; Colombo MDHP; Santos-Silva MC
Cytometry B Clin Cytom; 2018 Jul; 94(4):588-595. PubMed ID: 29476700
[TBL] [Abstract][Full Text] [Related]
46. Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma.
Gong JZ; Lagoo AS; Peters D; Horvatinovich J; Benz P; Buckley PJ
Am J Clin Pathol; 2001 Dec; 116(6):893-7. PubMed ID: 11764079
[TBL] [Abstract][Full Text] [Related]
47. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis.
Saksena A; Yin CC; Xu J; Li J; Zhou J; Wang SA; Lin P; Tang G; Wang L; Wang M; Miranda RN; Medeiros LJ; Li S
Hum Pathol; 2019 Jul; 89():71-80. PubMed ID: 31054894
[TBL] [Abstract][Full Text] [Related]
48. [Expression of CD200 in the bone marrow of chronic lymphocytic leukemia patients and its correlations with clinical prognosis].
Wang X; Zhang Z; Liu Y; Wang L; Yuan H; Xie P; Qu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jan; 30(1):75-8. PubMed ID: 24405602
[TBL] [Abstract][Full Text] [Related]
49. Variables affecting the quantitation of CD22 in neoplastic B cells.
Jasper GA; Arun I; Venzon D; Kreitman RJ; Wayne AS; Yuan CM; Marti GE; Stetler-Stevenson M
Cytometry B Clin Cytom; 2011 Mar; 80(2):83-90. PubMed ID: 20872890
[TBL] [Abstract][Full Text] [Related]
50. [Immunophenotype analysis of leukemic mantle cell lymphoma].
Zhao M; Wu YJ; Fan L; Qiu HR; Yang H; Zhang ZH; Xu W; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):371-6. PubMed ID: 23628035
[TBL] [Abstract][Full Text] [Related]
51. Detection of CD5 in B-cell chronic lymphoproliferative diseases by flow cytometry: a strong expression in B-cell chronic lymphocytic leukemia.
Cavalcanti Júnior GB; Sales VS; Cavalcanti e Silva DG; Lopes MC; Paiva Ade S; da Fonseca HE; do Nascimento Júniors FF; Fernandes MZ
Acta Cir Bras; 2005; 20 Suppl 1():101-7. PubMed ID: 16186976
[TBL] [Abstract][Full Text] [Related]
52. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
[TBL] [Abstract][Full Text] [Related]
53. CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance.
D'Arena G; De Feo V; Pietrantuono G; Seneca E; Mansueto G; Villani O; La Rocca F; D'Auria F; Statuto T; Valvano L; Arruga F; Deaglio S; Efremov DG; Sgambato A; Laurenti L
Front Oncol; 2020; 10():584427. PubMed ID: 33324560
[TBL] [Abstract][Full Text] [Related]
54. The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples.
Zhang YH; Liu J; Dawlett M; Guo M; Sun X; Gong Y
Cancer Cytopathol; 2014 Dec; 122(12):892-7. PubMed ID: 25056830
[TBL] [Abstract][Full Text] [Related]
55. Differential and tumor-specific expression of CD160 in B-cell malignancies.
Farren TW; Giustiniani J; Liu FT; Tsitsikas DA; Macey MG; Cavenagh JD; Oakervee HE; Taussig D; Newland AC; Calaminici M; Bensussan A; Jenner M; Gribben JG; Agrawal SG
Blood; 2011 Aug; 118(8):2174-83. PubMed ID: 21715317
[TBL] [Abstract][Full Text] [Related]
56. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
57. CD 200 - A useful marker in chronic B lymphoprolipherative disorders.
Iova A; Vlădăreanu A; Bumbea H; Begu M; Vasile D; Andruş E
J Med Life; 2012; 5(Spec Issue):66-70. PubMed ID: 31803290
[No Abstract] [Full Text] [Related]
58. Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies.
Kokhaei P; Abdalla AO; Hansson L; Mikaelsson E; Kubbies M; Haselbeck A; Jernberg-Wiklund H; Mellstedt H; Osterborg A
Clin Cancer Res; 2007 Jun; 13(12):3536-44. PubMed ID: 17575216
[TBL] [Abstract][Full Text] [Related]
59. CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol.
Ghazavi F; Clappier E; Lammens T; Suciu S; Caye A; Zegrari S; Bakkus M; Grardel N; Benoit Y; Bertrand Y; Minckes O; Costa V; Ferster A; Mazingue F; Plat G; Plouvier E; Poirée M; Uyttebroeck A; van der Werff-Ten Bosch J; Yakouben K; Helsmoortel H; Meul M; Van Roy N; Philippé J; Speleman F; Cavé H; Van Vlierberghe P; De Moerloose B
Haematologica; 2015 Oct; 100(10):1311-9. PubMed ID: 26137961
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
DiGiuseppe JA; Fuller SG; Borowitz MJ
Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
